These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 36027683)

  • 41. Enhanced protective immunity to CSFV E2 subunit vaccine by using IFN-γ as immunoadjuvant in weaning piglets.
    Zhang H; Wen W; Zhao Z; Wang J; Chen H; Qian P; Li X
    Vaccine; 2018 Nov; 36(48):7353-7360. PubMed ID: 30366801
    [TBL] [Abstract][Full Text] [Related]  

  • 42. The effect of vaccination with the PAV-250 strain classical swine fever (CSF) virus on the airborne transmission of CSF virus.
    Gonzalez C; Pijoan C; Ciprian A; Correa P; Mendoza S
    J Vet Med Sci; 2001 Sep; 63(9):991-6. PubMed ID: 11642288
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Efficacy and stability of a subunit vaccine based on glycoprotein E2 of classical swine fever virus.
    Bouma A; de Smit AJ; de Kluijver EP; Terpstra C; Moormann RJ
    Vet Microbiol; 1999 Apr; 66(2):101-14. PubMed ID: 10227472
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Chimeric (marker) C-strain viruses induce clinical protection against virulent classical swine fever virus (CSFV) and reduce transmission of CSFV between vaccinated pigs.
    de Smit AJ; Bouma A; van Gennip HG; de Kluijver EP; Moormann RJ
    Vaccine; 2001 Jan; 19(11-12):1467-76. PubMed ID: 11163670
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Efficacy of the classical swine fever (CSF) marker vaccine Porcilis Pesti in pregnant sows.
    Ahrens U; Kaden V; Drexler C; Visser N
    Vet Microbiol; 2000 Nov; 77(1-2):83-97. PubMed ID: 11042402
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Evaluation of an alternative method for determination of Protective Dose
    Manu M; Singha Mahapatra C; Pachauri R; Ompreethi B; Dhar P
    Virology; 2023 Apr; 581():139-144. PubMed ID: 36963269
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Investigation of chronic and persistent classical swine fever infections under field conditions and their impact on vaccine efficacy.
    Coronado L; Bohórquez JA; Muñoz-González S; Perez LJ; Rosell R; Fonseca O; Delgado L; Perera CL; Frías MT; Ganges L
    BMC Vet Res; 2019 Jul; 15(1):247. PubMed ID: 31307464
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Recombinant pseudorabies virus expressing E2 of classical swine fever virus (CSFV) protects against both virulent pseudorabies virus and CSFV.
    Tong W; Zheng H; Li GX; Gao F; Shan TL; Zhou YJ; Yu H; Jiang YF; Yu LX; Li LW; Kong N; Tong GZ; Li JC
    Antiviral Res; 2020 Jan; 173():104652. PubMed ID: 31751590
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Pre-registration efficacy study of a novel marker vaccine against classical swine fever on maternally derived antibody positive (MDA+) target animals.
    Farsang A; Lévai R; Barna T; Fábián K; Blome S; Belák K; Bálint Á; Koenen F; Kulcsár G
    Biologicals; 2017 Jan; 45():85-92. PubMed ID: 27756679
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Proportions and phenotypic expression of peripheral blood leucocytes in pigs vaccinated with an attenuated C strain and a subunit E2 vaccine against classical swine fever.
    Terzić S; Sver L; Valpotić I; Jemersić L; Lojkić M; Miletić Z; Orsolić N; Forsek J
    J Vet Med B Infect Dis Vet Public Health; 2003 May; 50(4):166-71. PubMed ID: 12916689
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Development of a marker vaccine candidate against classical swine fever based on the live attenuated vaccine C-strain.
    Han Y; Xie L; Yuan M; Ma Y; Sun H; Sun Y; Li Y; Qiu HJ
    Vet Microbiol; 2020 Aug; 247():108741. PubMed ID: 32768202
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Efficacy of E2-sub-unit marker and C-strain vaccines in reducing horizontal transmission of classical swine fever virus in weaner pigs.
    Dewulf J; Laevens H; Koenen F; Mintiens K; de Kruif A
    Prev Vet Med; 2004 Oct; 65(3-4):121-33. PubMed ID: 15488266
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Efficacy of intradermally administrated E2 subunit vaccines in reducing horizontal transmission of classical swine fever virus.
    Dortmans JC; Loeffen WL; Weerdmeester K; van der Poel WH; de Bruin MG
    Vaccine; 2008 Feb; 26(9):1235-42. PubMed ID: 18242794
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Efficacy of marker vaccine candidate CP7_E2alf against challenge with classical swine fever virus isolates of different genotypes.
    Blome S; Gabriel C; Schmeiser S; Meyer D; Meindl-Böhmer A; Koenen F; Beer M
    Vet Microbiol; 2014 Feb; 169(1-2):8-17. PubMed ID: 24411658
    [TBL] [Abstract][Full Text] [Related]  

  • 55. CP7_E2alf oral vaccination confers partial protection against early classical swine fever virus challenge and interferes with pathogeny-related cytokine responses.
    Renson P; Le Dimna M; Keranflech A; Cariolet R; Koenen F; Le Potier MF
    Vet Res; 2013 Feb; 44(1):9. PubMed ID: 23398967
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Efficacy of Suvaxyn CSF Marker (CP7_E2alf) in the presence of pre-existing antibodies against Bovine viral diarrhea virus type 1.
    Dräger C; Schröder C; König P; Tegtmeyer B; Beer M; Blome S
    Vaccine; 2016 Sep; 34(39):4666-4671. PubMed ID: 27523739
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Yeast-expressed classical swine fever virus glycoprotein E2 induces a protective immune response.
    Lin GJ; Liu TY; Tseng YY; Chen ZW; You CC; Hsuan SL; Chien MS; Huang C
    Vet Microbiol; 2009 Nov; 139(3-4):369-74. PubMed ID: 19625145
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Oral immunization of pigs against classical swine fever. Course of the disease and virus transmission after simultaneous vaccination and infection.
    Kaden V; Schurig U; Steyer H
    Acta Virol; 2001 Feb; 45(1):23-9. PubMed ID: 11394574
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Isolation and Characterization of a Moderately Virulent Classical Swine Fever Virus Emerging in China.
    Luo Y; Ji S; Liu Y; Lei JL; Xia SL; Wang Y; Du ML; Shao L; Meng XY; Zhou M; Sun Y; Qiu HJ
    Transbound Emerg Dis; 2017 Dec; 64(6):1848-1857. PubMed ID: 27658930
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Prevention of transplacental transmission of moderate-virulent classical swine fever virus after single or double vaccination with an E2 subunit vaccine.
    de Smit AJ; Bouma A; de Kluijver EP; Terpstra C; Moormann RJ
    Vet Q; 2000 Jul; 22(3):150-3. PubMed ID: 10952445
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.